Abstract
Background: Type 1 interferon is regarded as having an important role in the pathogenesis of dermatomyositis (DM). A recent report has shown that sarcoplasmic expression of myxovirus resistance A (MxA), one of the type 1 interferon-inducible proteins, can be used as a diagnostic marker of DM. However, the correlation between MxA expression and subtypes of DM remains unclear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
